Education
About Us
Working with TipRanks
Follow Us
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
ASX:RMD
RESEARCH TOOLSreports
RMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$27.05 - AU$40.75
Previous CloseN/A
Volume1.29M
Average Volume (3M)1.27M
Market Cap
AU$55.39B
Enterprise ValueAU$54.74B
Total Cash (Recent Filing)$210.25M
Total Debt (Recent Filing)$1.39B
Price to Earnings (P/E)27.9
Beta0.84
Next Earnings
Apr 24, 2025EPS Estimate
0.38Last Dividend Ex-Date
Feb 12, 2025Dividend Yield0.88%
Share Statistics
EPS (TTM)1.28
Shares Outstanding1,468,669,100
10 Day Avg. Volume1,193,990
30 Day Avg. Volume1,267,411
Financial Highlights & Ratios
PEG Ratio0.67
Price to Book (P/B)N/A
Price to Sales (P/S)5.69
Price to Cash Flow (P/CF)22.30
P/FCF Ratio22.30
Enterprise Value/Market Cap0.99
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit20.62
Enterprise Value/Ebitda31.27
Forecast
1Y Price Target
AU$44.53Price Target Upside18.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
---
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh News
PremiumCompany Announcements
ResMed CFO Executes Stock Sale Under Rule 10b5-1 Plan
PremiumCompany Announcements
ResMed Executive Reports Changes in Stock Ownership
PremiumCompany Announcements
Resmed Inc Announces Proposed Sale of Securities
PremiumCompany Announcements
ResMed Inc. CEO Reports Stock Transactions Under Rule 10b5-1 Plan---
Bulls Say, Bears Say
Bulls Say
EarningsThe company reported strong devices growth, contributing to a solid Q2 performance with earnings exceeding expectations.
Financial HealthShare buybacks worth US$75 million were executed during the quarter, which can signal confidence in the company's financial health.
Bears Say
Market CompetitionThere is no clarity on Philips’ return to the US market, which may benefit RMD in the short term.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
RMD FAQ
What was Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price range in the past 12 months?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh lowest share price was AU$27.05 and its highest was AU$40.75 in the past 12 months.
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap is AU$55.39B.
When is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date is Apr 24, 2025 which is in 42 days.
How were Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s earnings last quarter?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh released its earnings results on Jan 30, 2025. The company reported AU$0.387 earnings per share for the quarter, beating the consensus estimate of AU$0.37 by AU$0.018.
Is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh overvalued?
According to Wall Street analysts Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price is currently Undervalued.
Does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pay dividends?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pays a Annually dividend of AU$0.317 which represents an annual dividend yield of 0.88%. See more information on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh dividends here
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate is 0.38.
How many shares outstanding does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh have?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,468,669,100 shares outstanding.
What happened to Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price movement after its last earnings report?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh reported an EPS of AU$0.387 in its last earnings report, beating expectations of AU$0.37. Following the earnings report the stock price went down -0.792%.
Which hedge fund is a major shareholder of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh?
Currently, no hedge funds are holding shares in AU:RMD
---
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$44.53 (18.68% Upside)
AU$44.53 (18.68% Upside)
Blogger Sentiment
Bullish
AU:RMD Sentiment 94%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.70%
12-Months-Change
Fundamentals
Return on Equity
25.16%
Trailing 12-Months
Asset Growth
13.98%
Trailing 12-Months
Company Description
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
---
RMD Revenue Breakdown
88.21% Sleep and Respiratory Care
11.79% Software as a Service
---
RMD Stock 12 Month Forecast
Average Price Target
AU$44.53
▲(18.68% Upside)
Technical Analysis
Best Analysts Covering RMD
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+9.99%
reiterated a buy rating last month
Copying Andrew Paine's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +9.99% per trade.
---